1Mcunicr F. Infcclion in prlicnls with aeule lcukcmin and lymphomin. In; Mandell GL Douclas RG. Bennetl JE. eds. prineipks and practiee of in feetious disease[J]. New York,Churehill Livinastone,1995.2675-2686.
5Marl E,Florian! I,Tinassi A,et al. Efficacy of adjuvant chemotherapy after cur- ative resection for gastric Cancer: a meta- analysis of published randomized trials [J]. Ann Oncol 2000 , 11 : 837- 43.
6Hartgrink HH,van de Velde CJ, Putter H, et al. Extended lymph node lisec tion for gastric cancer:who may benefit Final Results of the randomized Dutch gastric cancer group trial[J]. J Clin Oncol 2004 ; 22 : 2069- 77.
7Forman D, Burley VJ. Gastric cancer, global pattern of the disease and an overview of environmental risk factors[J]. Best Pract Res Clin Gastroenterol , 2006,20 : 633- 649.
8Briasoulis E,Liakakos T,Dova L,et al. Selecting a specific pre or postoperative adjuvant therapy for individual patients with operable gas-tric cancer[J]. Expert Rev Anticancer Ther, 2006,6 : 931- 939.
9Roth AD, Fazio N, Stupp R, et al. Docetaxel, cisplatin, and fluoroura- cil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:a randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research[J]. J Clin Oncol, 2007,25:3217-3223.
10Mari E, Floriani I, Tinazzi A, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta- analysis of published randomised trials. A study of the GISCAD (Gruppo haliano per lo Studio dei Carcinomi dell'Apparato Digerente)[J]. Ann Oncol, 2000, 11(7): 837-843.
